Combined Network Pharmacology and Molecular Docking to Verify the Treatment of Type 2 Diabetes with <i>Pueraria Lobata Radix</i> and <i>Salviae Miltiorrhizae Radix</i>

<div>Molecular docking of luteolin with core target genes. (a) VEGFA, (b) MMP9, (c) AKT1, (d) NOS3, and (e) VCAM1, respectively.</div>

Computational and Mathematical Methods in Medicine

fig11

Figure 11

Figure 11: Combined Network Pharmacology and Molecular Docking to Verify the Treatment of Type 2 Diabetes with <i>Pueraria Lobata Radix</i> and <i>Salviae Miltiorrhizae Radix</i> 

Figure 11 | Combined Network Pharmacology and Molecular Docking to Verify the Treatment of Type 2 Diabetes with Pueraria Lobata Radix and Salviae Miltiorrhizae Radix 